In conclusion, we found that a molecular prognostic model, comprised of expression of EGFR, p-Sp1, and Fascin proteins, was significantly associated with poor ESCC clinical outcome. The gene discussed is FSCN1; the disease is esophageal squamous cell carcinoma.